Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference121 articles.
1. Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database;Anderson;Breast Cancer Res Treat,2002
2. Update on the treatment of patients with hormone receptor-positive breast cancer;Cleator;Clin Breast Cancer,2009
3. New therapeutic approaches in breast cancer;Davies;Maturitas,2011
4. New strategies in estrogen receptor-positive breast cancer;Johnston;Clin Cancer Res,2010
5. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer;Baselga;N Engl J Med,2012
Cited by 257 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Developmental trajectory and sex differences in auditory processing in a PTEN-deletion model of autism spectrum disorders;Neurobiology of Disease;2024-10
2. Inhibitors of the mTOR signaling pathway can play an important role in breast cancer immunopathogenesis;Cell Biology International;2024-08-20
3. Development of a reliable cell-based reporter gene assay to measure the bioactivity of anti-HER2 therapeutic antibodies;Journal of Pharmaceutical and Biomedical Analysis;2024-08
4. Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence;Cell Metabolism;2024-08
5. Combining In Vitro, In Vivo, and Network Pharmacology Assays to Identify Targets and Molecular Mechanisms of Spirulina-Derived Biomolecules against Breast Cancer;Marine Drugs;2024-07-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3